Erleada
| Erleada | |
|---|---|
| Term | Erleada |
| Short definition | Erleada (er-LEE-duh) A drug used to treat prostate cancer that has spread to other parts of the body and is castration-sensitive (has responded to treatments that lower testosterone levels) and prostate cancer that Has not spread to other parts of the body and is resistant to castration (has not responded to treatments that lower testosterone levels). Erleada attaches to proteins called androgen receptors, which are found in some prostate cancer cells. |
| Type | Cancer terms |
| Specialty | Oncology |
| Language | English |
| Source | NCI |
| Comments | |
Erleada - (pronounced) (er-LEE-duh) A drug used to treat prostate cancer that has spread to other parts of the body and is castration-sensitive (has responded to treatments that lower testosterone levels) and prostate cancer that Has not spread to other parts of the body and is resistant to castration (has not responded to treatments that lower testosterone levels). Erleada attaches to proteins called androgen receptors, which are found in some prostate cancer cells. These proteins bind to androgens (male hormones) and can cause cancer cells to grow. Erleada blocks these proteins and can prevent cancer cells from growing. It's a type of antiandrogen. Also called apalutamide
External links
- Medical encyclopedia article on Erleada
- Wikipedia's article - Erleada
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski